Ladenburg Thalmann Financial Services’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $400K | Sell |
2,352
-313
| -12% | -$53.2K | ﹤0.01% | 2004 |
|
2019
Q3 | $474K | Buy |
2,665
+1,726
| +184% | +$307K | ﹤0.01% | 1815 |
|
2019
Q2 | $245K | Sell |
939
-537
| -36% | -$140K | ﹤0.01% | 2324 |
|
2019
Q1 | $421K | Sell |
1,476
-2,361
| -62% | -$673K | ﹤0.01% | 1827 |
|
2018
Q4 | $1.25M | Buy |
3,837
+1,108
| +41% | +$360K | 0.01% | 910 |
|
2018
Q3 | $1.23M | Buy |
2,729
+377
| +16% | +$170K | 0.01% | 1002 |
|
2018
Q2 | $682K | Hold |
2,352
| – | – | 0.01% | 1320 |
|
2018
Q1 | $682K | Buy |
2,352
+787
| +50% | +$228K | 0.01% | 1320 |
|
2017
Q4 | $294K | Buy |
1,565
+64
| +4% | +$12K | ﹤0.01% | 1911 |
|
2017
Q3 | $253K | Sell |
1,501
-76
| -5% | -$12.8K | ﹤0.01% | 1924 |
|
2017
Q2 | $226K | Sell |
1,577
-1
| -0.1% | -$143 | ﹤0.01% | 1922 |
|
2017
Q1 | $198K | Sell |
1,578
-9,805
| -86% | -$1.23M | ﹤0.01% | 1920 |
|
2016
Q4 | $1.28M | Sell |
11,383
-2,330
| -17% | -$262K | 0.02% | 721 |
|
2016
Q3 | $1.76M | Buy |
13,713
+1,649
| +14% | +$212K | 0.03% | 539 |
|
2016
Q2 | $1.32M | Sell |
12,064
-763
| -6% | -$83.4K | 0.02% | 632 |
|
2016
Q1 | $1.22M | Sell |
12,827
-228
| -2% | -$21.6K | 0.02% | 609 |
|
2015
Q4 | $1.18M | Buy |
13,055
+11,000
| +535% | +$993K | 0.02% | 611 |
|
2015
Q3 | $191K | Buy |
2,055
+1,130
| +122% | +$105K | ﹤0.01% | 1517 |
|
2015
Q2 | $61K | Sell |
925
-1,425
| -61% | -$94K | ﹤0.01% | 2451 |
|
2015
Q1 | $168K | Buy |
2,350
+1,750
| +292% | +$125K | ﹤0.01% | 1700 |
|
2014
Q4 | $23K | Buy |
600
+100
| +20% | +$3.83K | ﹤0.01% | 2907 |
|
2014
Q3 | $12K | Hold |
500
| – | – | ﹤0.01% | 3004 |
|
2014
Q2 | $13K | Hold |
500
| – | – | ﹤0.01% | 2953 |
|
2014
Q1 | $13K | Hold |
500
| – | – | ﹤0.01% | 2828 |
|
2013
Q4 | $13K | Sell |
500
-200
| -29% | -$5.2K | ﹤0.01% | 2790 |
|
2013
Q3 | $13K | Buy |
700
+500
| +250% | +$9.29K | ﹤0.01% | 2720 |
|
2013
Q2 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 3163 |
|